PubMed:22825334 / 371-566 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T72","span":{"begin":10,"end":23},"obj":"CVCL_5552"},{"id":"T73","span":{"begin":15,"end":19},"obj":"D002285"},{"id":"T75","span":{"begin":15,"end":19},"obj":"D002285"},{"id":"T77","span":{"begin":20,"end":23},"obj":"CHEBI:17905"},{"id":"T78","span":{"begin":24,"end":29},"obj":"D006801"},{"id":"T79","span":{"begin":30,"end":36},"obj":"UBERON:0000310"},{"id":"T80","span":{"begin":30,"end":43},"obj":"D001943"},{"id":"T81","span":{"begin":30,"end":43},"obj":"D001943"},{"id":"T83","span":{"begin":74,"end":82},"obj":"Q17391"},{"id":"T84","span":{"begin":74,"end":82},"obj":"PR:000006048"},{"id":"T85","span":{"begin":74,"end":82},"obj":"Q09760"},{"id":"T86","span":{"begin":74,"end":82},"obj":"P53202"},{"id":"T87","span":{"begin":74,"end":82},"obj":"Q9JLV5"},{"id":"T88","span":{"begin":74,"end":82},"obj":"Q13618"},{"id":"T89","span":{"begin":74,"end":82},"obj":"Q54NZ5"},{"id":"T90","span":{"begin":74,"end":82},"obj":"B5DF89"},{"id":"T91","span":{"begin":74,"end":82},"obj":"A4IHP4"},{"id":"T94","span":{"begin":140,"end":164},"obj":"D002285"},{"id":"T95","span":{"begin":140,"end":164},"obj":"D002285"},{"id":"T101","span":{"begin":166,"end":170},"obj":"CVCL_5552"},{"id":"T100","span":{"begin":166,"end":170},"obj":"D002285"},{"id":"T102","span":{"begin":166,"end":170},"obj":"D002285"},{"id":"T103","span":{"begin":184,"end":194},"obj":"D002277"},{"id":"T104","span":{"begin":184,"end":194},"obj":"D002277"}],"text":"Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas."}

{"project":"Allie","denotations":[{"id":"SS1_22825334_3_0","span":{"begin":140,"end":164},"obj":"expanded"},{"id":"SS2_22825334_3_0","span":{"begin":166,"end":170},"obj":"abbr"}],"relations":[{"id":"AE1_22825334_3_0","pred":"abbreviatedTo","subj":"SS1_22825334_3_0","obj":"SS2_22825334_3_0"}],"text":"Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas."}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T4","span":{"begin":0,"end":195},"obj":"DRI_Outcome"}],"text":"Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas."}

{"project":"PubMed_ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":195},"obj":"DRI_Outcome"}],"text":"Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas."}

{"project":"PubmedHPO","denotations":[{"id":"T3","span":{"begin":30,"end":43},"obj":"HP_0003002"},{"id":"T4","span":{"begin":30,"end":43},"obj":"HP_0100013"},{"id":"T5","span":{"begin":37,"end":43},"obj":"HP_0002664"}],"text":"Using the MCF10DCIS.com human breast cancer xenograft model, we show that Cullin-3 is increasingly expressed during progression from comedo ductal carcinoma in situ (DCIS) to invasive carcinomas."}